Hongkwan Cho
Johns Hopkins University
H-index: 13
North America-United States
Top articles of Hongkwan Cho
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Use of sgc activators for the treatment of ophthalmologic diseases | 2023/11/2 | ||
Suppression of subretinal neovascularization in Vldlr knockout mice by systemic administration of a targeted VEGF-receptor inhibitor | Investigative Ophthalmology & Visual Science | Shirley Wu Zhenhua Xu Tony Wu Lijuan Wu Hongkwan Cho | 2023/6/1 |
Myeloid cell modulation by a GLP-1 receptor agonist regulates retinal angiogenesis in ischemic retinopathy | JCI insight | Lingli Zhou Zhenhua Xu Yumin Oh Rico Gamuyao Grace Lee | 2021/12/12 |
Neuroprotective and Anti-Inflammatory Effects of a Novel Soluble Guanylate Cyclase Activator Runcaciguat in Ischemic Retinal Disease Animal Models | Investigative Ophthalmology & Visual Science | Elia J Duh William Schubert Zhenhua Xu Carsten Terjung Hongkwan Cho | 2021/6/21 |
Targeted Therapy: Dendrimer‐Triamcinolone Acetonide Reduces Neuroinflammation, Pathological Angiogenesis, and Neuroretinal Dysfunction in Ischemic Retinopathy (Adv. Therap. 2/2021) | Advanced Therapeutics | Hongkwan Cho Siva P Kambhampati Michael J Lai Lingli Zhou Grace Lee | 2021/2 |
Inhibition of the Keap1-Nrf2 protein-protein interaction protects retinal cells and ameliorates retinal ischemia-reperfusion injury | Free Radical Biology and Medicine | Qiaoyan Hui Marcus Karlstetter Zhenhua Xu Jing Yang Lingli Zhou | 2020/1/1 |
iPSC-derived endothelial cell response to hypoxia via SDF1a/CXCR4 axis facilitates incorporation to revascularize ischemic retina | Jci Insight | Hongkwan Cho Bria L Macklin Ying-Yu Lin Lingli Zhou Michael J Lai | 2020/3/3 |
Dendrimer‐Triamcinolone Acetonide Reduces Neuroinflammation, Pathological Angiogenesis, and Neuroretinal Dysfunction in Ischemic Retinopathy | Advanced Therapeutics | Hongkwan Cho Siva P Kambhampati Michael J Lai Lingli Zhou Grace Lee | 2020 |
Co-Authors
